Method of preventing pathological levels of factor VIII before, during and/or after a surgical procedure by controlling psychic and somatic stress

• US 7,678,761 B2
• Filed: 04/18/2007
• Issued: 03/16/2010
• Est. Priority Date: 03/15/2005
• Status: Expired due to Fees

• Current Assignee: Lewis S. Coleman
• Original Assignee: Lewis S. Coleman
• Inventors: Coleman, Lewis S.
• Primary Examiner(s): Robinson; Hope A
• Application Number:
  US11/787,820
• Publication Number:
  US 20070191430A1
• Time in Patent Office: 1,063 Days
• Field of Search: None
• US Class Current: 514/19.4
• CPC Class Codes: A61K 31/36 Compounds containing methylenedioxyphenyl groups, e.g. sesamin
• CPC Class Codes: A61K 31/37 Coumarins, e.g. psoralen

Abstract

A method of providing general anesthesia to an organism that improves surgical outcome by controlling a psychic and a somatic surgical stress before, during, and after a surgical procedure by preventing a pathological elevation of Factor VIII in the blood of the organism, comprising the steps of controlling the psychic stress in the organism by administering to the organism an anesthetic or hypnotic agent; controlling the somatic stress by administering to the organism an opioid and/or lidocaine; maintaining a normal body temperature of the organism; minimizing a non-surgical stress stimuli; and allowing a mild hypercarbia to support a respiratory drive in the presence of an opioid dosage. The method may further comprise the step of giving additional doses of an opioid as necessary to prevent sympathetic nervous system activation.

Claims

1. A method of decreasing Factor VIII elevation in blood by controlling psychic and somatic surgical stress, said method comprising the steps of:

a. controlling the psychic stress in the organism by administering to the organism at least one compound selected from the group consisting of a Sevoflurance, an anesthetic inhalation agent, and an intravenous hypnotic drug;

b. controlling the somatic stress by administering to the organism at least one compound selected from the group consisting of an opioid and lidocaine;

c. maintaining a normal body temperature of the organism;

d. minimizing a non-surgical stress stimuli; and

e. allowing a mild hypercarbia to support a respiratory drive in the presence of an opioid dosage to offset a respiratory effect of the opioid and encourage cardiac output, wherein elevation of Factor VIII is decreased.

2. The method of claim 1, wherein the concentration of Sevoflurance is about 0.5 minimum alveolar concentration (“

MAC”

).

3. The method of claim 1, wherein, the opioid comprises a compound selected from the group consisting of a Fentanyl and a sufentanil.

4. The method of claim 3, wherein Fentanyl is administered intravenously in a dose of about two micrograms/Kg to about ten micrograms/Kg before surgical incision.

5. The method of claim 1, further comprising the step of giving additional doses of an opioid as necessary to prevent sympathetic nervous system activation.

6. The method of claim 1, further comprising the step of giving additional doses of an opioid to maintain a respiratory rate of about 8 breaths per minute to about 12 breaths per minute before emergence.

7. The method of claim 1, wherein the lidocaine is infused intravenously to the organism in a dosage of approximately 0.05 mg/Kg per hour to approximately 1.0 mg/Kg per hour.

8. The method of claim 1, wherein the non-surgical stressful stimulus is selected from the group consisting of a hypothermia, a hypocarbia, a hypoxemia, a hyperoxia, a hypovolemia and a hypervolemia.

9. The method of claim 1, wherein an endotracheal intubation and a controlled ventilation are used to cause a mild hypercarbia.

10. The method of claim 9, wherein the mild hypercarbia is approximately 50 torr.

11. The method of claim 3, wherein sufentanil is administered intravenously in a dose of about two micrograms/Kg to about ten micrograms/Kg before surgical incision.